Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells

International Journal of Oncology

Volumn 34, Issue 5, 2009, Pages 1221-1230

  Choi, Myoung Suk ^a   Oh, Ju Hoon ^a   Kim, Sun Mi ^a   Jung, Hai Young ^a   Yoo, Hwan Soo ^a   Lee, Yong Moon ^a   Moon, Dong Cheul ^a   Han, Sang Bae ^a   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Apoptosis; Berberine; p53; Prostate cancer cells

Indexed keywords

BERBERINE; CASPASE 3; CISPLATIN; PIFITHRIN ALPHA; PROTEIN BAX; PROTEIN P53; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BERBERINE; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67649438659     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000250     Document Type: Article

References (45)

1. Kelloff GJ, Crowell JA, Steele VE, et al: Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130: 467-471, 2000.
2. Ahmad N, Feyes DK, Nieminen AL, Agarwal R and Mukhtar H: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89: 1881-1886, 1997.
3. Deigner HP and Kinscherf R: Modulating apoptosis: current applications and prospects for future drug development. Curr Med Chem 6: 399-414, 1999.
4. Buolamwini JK: Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des 6: 379-392, 2000.
5. McDonald ER and El-Deiry WS: Cell cycle control as a basis for cancer drug development. Int J Oncol 16: 871-886, 2000.
6. Takase H, Yamamoto K, Ito K and Yumioka E: Pharmacological studies on antidiarrheal effects of berberine and geranin herb. Nippon Yakurigaku Zasshi 2: 101-112, 1993.
7. Huang WM, Wu ZD and Gan YQ: Effects of berberine on ischemic ventricular arrhythmia. Zhonghua Xin Xue Guan Bing Za Zhi 5: 300-301, 1989.
8. Kuo CL, Chi CW and Liu TY: The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203: 127-137, 2004.
9. Hano K: Pharmacological studies on metabolism of cancer tissues: pharmacological studies on carcinostatic effects of some plant components and their derivatives. Gann 48: 443-450, 1957.
10. Hoshi A, Ikekawa T, Ikeda Y, Shirakawa S and Iigo M: Antitumor activity of berberrubine derivatives. Gann 67: 321-325, 1976.
11. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S and Fujiwara H: Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 2: 227-233, 1999.
12. Lin JG, Chung JG and Wu LT: Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am J Chin Med 27: 265-275, 1999.
13. Mazzini S, Bellucci MC and Mondelli R: Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide d(AAGAATTCTT)(2). Bioorg Med Chem 11: 505-514, 2003.
14. Qin Y, Pang JY, Chen WH, Cai Z and Jiang ZH: Synthesis, DNA-binding affinities, and binding mode of berberine dimmers. Bioorg Med Chem 14: 25-32, 2006.
15. Tse WC and Boger DL: A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinity. Acc Chem Res 37: 61-69, 2004.
16. Liu LF: DNA topoisomerase poisons as antitumor drugs. Ann Rev Biochem 58: 351-375, 1989.
17. Hainaut P and Hollstein M: p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77: 81-137, 2000.
18. Vousden KH and Lu X: Live or let die: the cell's response p53. Nat Rev Cancer 2: 594-604, 2002.
19. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
20. Hoffman WH, Biade S, Zilfou JT, Chen J and Murphy M: Transcriptional repression of the anti-apoptotic survivin gene by wild-type p53. J Biol Chem 277: 3247-3257, 2002.
21. Olitvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell-death. Cell 74: 609-619, 1993.
22. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933, 2001.
23. Weir NM, Selvendiran K, Kutala VK, et al: Curcumin induces G(2)/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6: 178-184, 2007.
24. Kuo PL, Chiang LC and Lin CC: Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 72: 23-34, 2002.
25. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML and Mukhtar H: Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22: 4851-4859, 2003.
26. Ito K, Nakazato T, Yamato K, et al: Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res 64: 1071-1078, 2004.
27. Ahn KS, Park KS, Jung KM, et al: Inhibitory effect of glycolic acid on ultraviolet B-induced c-fos expression, AP-1 activation and p53-p21 response in a human keratinocyte cell line. Cancer Lett 186: 125-135, 2002.
28. Son DJ, Park MH, Chae SJ, et al: Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor kappaB. Mol Cancer Ther 6: 675-683, 2007.
29. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
30. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV and Gudkov AV: A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737, 1999.
31. Lin JP, Yang JS, Lee JH, Hsieh WT and Chung JG: Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 12: 21-28, 2006.
32. Mantena SK, Sharma SD and Katiyar SK: Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase-3 and PARP. Carcinogenesis 27: 2018-2027, 2006.
33. Mantena SK, Sharma SD and Katiyar SK: Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5: 296-308, 2006.
34. Letasiova S, Jantova S, Muckova M, et al: Antiproliferative activity of berberine in vitro and in vivo. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149: 461-463, 2005.
35. Kastan MB, Canman CE and Leonard CJ: P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14: 3-15, 1995.
36. Jiang XH, Wong BC, Yuen St, et al: Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int J Cancer 91: 173-179, 2001.
37. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC and Chung JG: Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 25: 971-979, 2005.
38. Hsu YL, Cho CY, Kuo PL, Huang YT and Lin CC: Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther 318: 484-494, 2006.
39. Molinari M: Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33: 261-274, 2000.
40. Jantova S, Cipak L and Letasiova S: Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. Toxicol In Vitro 21: 25-31, 2007.
41. Lin CC, Kao ST, Chen GW, Ho HC and Chung JG: Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 26: 227-242, 2006.
42. Hwang JM, Kuo HC, Tseng TH, Liu JY and Chu CY: Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol 80: 62-73, 2006.
43. Gleave M, Goldenberg SL, Bruchovsky N and Rennie P: Intermittent androgen suppression for prostate cancer: rationale and clinical experience. Prostate Cancer Prostatic Dis 1: 289-296, 1998.
44. Ivanov NI, Cowell SP, Brown P, Rennie PS, Guns ES and Cox ME: Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr 26: 252-263, 2007.
45. Maria McCrohan A, Morrissey C, O'Keane C, et al: Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines. Cancer 106: 2743-2752, 2006.